1069 — China Health Technology Holding Balance Sheet
0.000.00%
Last trade - 00:00- HK$40.38m
- HK$160.21m
- CNY47.61m
Annual balance sheet for China Health Technology Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2019 December 31st | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.18 | 1.82 | 1.11 | 4.33 | 3.23 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.46 | 6.35 | 5.53 | 10.4 | 18.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17.5 | 10.4 | 12.9 | 22.6 | 47.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 571 | 76.5 | 80.6 | 118 | 131 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 589 | 86.9 | 93.5 | 141 | 178 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 177 | 307 | 348 | 443 | 49.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 336 | 364 | 400 | 457 | 165 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 252 | -277 | -307 | -317 | 13 |
| Total Liabilities & Shareholders' Equity | 589 | 86.9 | 93.5 | 141 | 178 |
| Total Common Shares Outstanding |